مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

130
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

109
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

Prescribing Oral Contraceptives in Women With Breast Diseases: A Matter of Concern for the Gynecologist

Pages

  55-66

Abstract

 Results: Oral contraceptives are contraindicated in women with current or previous Breast Cancer. Among women at high risk for Breast Cancer, those with preceding chest wall irradiation should not use pills, while these are allowed in cases with BRCA mutations or with a positive family history of Breast Cancer. Oral contraceptives may be beneficial for benign breast diseases. For low-risk woman, pills either pose no risk or may induce a very mild risk for Breast Cancer. Methods: We first reviewed international clinical guidelines about the subject. Then, a comprehensive search of the literature was carried out using appropriate keywords. Clinical trials, population-based or cohort studies, nested case-control studies, and narrative/systematic reviews were reviewed and relevant data were extracted. Background: The association of exogenous steroid hormones with breast malignancy has long been, and still is, a subject of investigation. This manuscript, as part of a series of articles about effects of exogenous sex hormones on breast conditions, reviews the adverse and beneficial effects of oral contraceptives in various entities separately: benign and malignant breast diseases, women with risk factors of Breast Cancer, and the general population. Conclusion: Oral contraceptives are generally safe regarding breast diseases except in Breast Cancer patients or high-risk women, especially those with a history of chest wall irradiation.

Cites

References

  • No record.

    • Cite

    APA: Copy

    ALIPOUR, SADAF, & ESKANDARI, AMIRHOSSEIN. (2019). Prescribing Oral Contraceptives in Women With Breast Diseases: A Matter of Concern for the Gynecologist. ARCHIVES OF BREAST CANCER, 6(2), 55-66. SID. https://sid.ir/paper/774214/en

    Vancouver: Copy

    ALIPOUR SADAF, ESKANDARI AMIRHOSSEIN. Prescribing Oral Contraceptives in Women With Breast Diseases: A Matter of Concern for the Gynecologist. ARCHIVES OF BREAST CANCER[Internet]. 2019;6(2):55-66. Available from: https://sid.ir/paper/774214/en

    IEEE: Copy

    SADAF ALIPOUR, and AMIRHOSSEIN ESKANDARI, “Prescribing Oral Contraceptives in Women With Breast Diseases: A Matter of Concern for the Gynecologist,” ARCHIVES OF BREAST CANCER, vol. 6, no. 2, pp. 55–66, 2019, [Online]. Available: https://sid.ir/paper/774214/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button